Fimasartan (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Fimasartan" in English language version.

refsWebsite

Global rank English rank

12nih.gov

4^th place

10doi.org

2^nd place

3semanticscholar.org

11^th place

8^th place

1cvpharmacology.com

low place

1rosminzdrav.ru

low place

cvpharmacology.com

Klabunde RE (15 March 2007). "Angiotensin Receptor Blockers (ARBs)". CV Pharmacology.

doi.org

Lee HY, Oh BH (July 2016). "Fimasartan: A New Angiotensin Receptor Blocker". Drugs. 76 (10): 1015–22. doi:10.1007/s40265-016-0592-1. PMID 27272555. S2CID 3067660.
Pradhan A, Gupta V, Sethi R (July 2019). "Fimasartan: A new armament to fight hypertension". Journal of Family Medicine and Primary Care. 8 (7): 2184–2188. doi:10.4103/jfmpc.jfmpc_300_19. PMC 6691418. PMID 31463228.
"Fimasartan". American Journal of Cardiovascular Drugs. 11 (4): 249–252. 2011. doi:10.2165/11533640-000000000-00000. PMID 21740078.
Burnier M (February 2001). "Angiotensin II type 1 receptor blockers". Circulation. 103 (6): 904–12. doi:10.1161/01.cir.103.6.904. PMID 11171802.
Wynne BM, Chiao CW, Webb RC (2009). "Vascular Smooth Muscle Cell Signaling Mechanisms for Contraction to Angiotensin II and Endothelin-1". Journal of the American Society of Hypertension. 3 (2): 84–95. doi:10.1016/j.jash.2008.09.002. PMC 2704475. PMID 20161229.
Neal B, MacMahon S, Chapman N (December 2000). "Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration". Lancet. 356 (9246): 1955–64. doi:10.1016/s0140-6736(00)03307-9. PMID 11130523. S2CID 46148907.
Harada K, Sugaya T, Murakami K, Yazaki Y, Komuro I (November 1999). "Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction". Circulation. 100 (20): 2093–9. doi:10.1161/01.cir.100.20.2093. PMID 10562266.
Phillips PA (July 1999). "Interaction between endothelin and angiotensin II". Clinical and Experimental Pharmacology & Physiology. 26 (7): 517–8. doi:10.1046/j.1440-1681.1999.03069.x. PMID 10405777. S2CID 27296727.
Sun Y, Zhang JQ, Zhang J, Ramires FJ (August 1998). "Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart". Journal of Molecular and Cellular Cardiology. 30 (8): 1559–69. doi:10.1006/jmcc.1998.0721. PMID 9737942.
Gu N, Kim BH, Lim KS, Kim SE, Nam WS, Yoon SH, Cho JY, Shin SG, Jang IJ, Yu KS (July 2012). "The effect of fimasartan, an angiotensin receptor type 1 blocker, on the pharmacokinetics and pharmacodynamics of warfarin in healthy Korean male volunteers: a one-sequence, two-period crossover clinical trial". Clinical Therapeutics. 34 (7): 1592–600. doi:10.1016/j.clinthera.2012.06.004. PMID 22727611.

nih.gov

pubmed.ncbi.nlm.nih.gov

Lee HY, Oh BH (July 2016). "Fimasartan: A New Angiotensin Receptor Blocker". Drugs. 76 (10): 1015–22. doi:10.1007/s40265-016-0592-1. PMID 27272555. S2CID 3067660.
Pradhan A, Gupta V, Sethi R (July 2019). "Fimasartan: A new armament to fight hypertension". Journal of Family Medicine and Primary Care. 8 (7): 2184–2188. doi:10.4103/jfmpc.jfmpc_300_19. PMC 6691418. PMID 31463228.
"Fimasartan". American Journal of Cardiovascular Drugs. 11 (4): 249–252. 2011. doi:10.2165/11533640-000000000-00000. PMID 21740078.
Burnier M (February 2001). "Angiotensin II type 1 receptor blockers". Circulation. 103 (6): 904–12. doi:10.1161/01.cir.103.6.904. PMID 11171802.
Wynne BM, Chiao CW, Webb RC (2009). "Vascular Smooth Muscle Cell Signaling Mechanisms for Contraction to Angiotensin II and Endothelin-1". Journal of the American Society of Hypertension. 3 (2): 84–95. doi:10.1016/j.jash.2008.09.002. PMC 2704475. PMID 20161229.
Neal B, MacMahon S, Chapman N (December 2000). "Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration". Lancet. 356 (9246): 1955–64. doi:10.1016/s0140-6736(00)03307-9. PMID 11130523. S2CID 46148907.
Harada K, Sugaya T, Murakami K, Yazaki Y, Komuro I (November 1999). "Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction". Circulation. 100 (20): 2093–9. doi:10.1161/01.cir.100.20.2093. PMID 10562266.
Phillips PA (July 1999). "Interaction between endothelin and angiotensin II". Clinical and Experimental Pharmacology & Physiology. 26 (7): 517–8. doi:10.1046/j.1440-1681.1999.03069.x. PMID 10405777. S2CID 27296727.
Sun Y, Zhang JQ, Zhang J, Ramires FJ (August 1998). "Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart". Journal of Molecular and Cellular Cardiology. 30 (8): 1559–69. doi:10.1006/jmcc.1998.0721. PMID 9737942.
Gu N, Kim BH, Lim KS, Kim SE, Nam WS, Yoon SH, Cho JY, Shin SG, Jang IJ, Yu KS (July 2012). "The effect of fimasartan, an angiotensin receptor type 1 blocker, on the pharmacokinetics and pharmacodynamics of warfarin in healthy Korean male volunteers: a one-sequence, two-period crossover clinical trial". Clinical Therapeutics. 34 (7): 1592–600. doi:10.1016/j.clinthera.2012.06.004. PMID 22727611.

ncbi.nlm.nih.gov

Pradhan A, Gupta V, Sethi R (July 2019). "Fimasartan: A new armament to fight hypertension". Journal of Family Medicine and Primary Care. 8 (7): 2184–2188. doi:10.4103/jfmpc.jfmpc_300_19. PMC 6691418. PMID 31463228.
Wynne BM, Chiao CW, Webb RC (2009). "Vascular Smooth Muscle Cell Signaling Mechanisms for Contraction to Angiotensin II and Endothelin-1". Journal of the American Society of Hypertension. 3 (2): 84–95. doi:10.1016/j.jash.2008.09.002. PMC 2704475. PMID 20161229.

rosminzdrav.ru

grls.rosminzdrav.ru

"Kanarb (fimasartan) film-coated tablets. Registration Certificate". Russian State Register of Medicines (in Russian). JSC R-Pharm. Retrieved 1 September 2020.

semanticscholar.org

api.semanticscholar.org

Lee HY, Oh BH (July 2016). "Fimasartan: A New Angiotensin Receptor Blocker". Drugs. 76 (10): 1015–22. doi:10.1007/s40265-016-0592-1. PMID 27272555. S2CID 3067660.
Neal B, MacMahon S, Chapman N (December 2000). "Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration". Lancet. 356 (9246): 1955–64. doi:10.1016/s0140-6736(00)03307-9. PMID 11130523. S2CID 46148907.
Phillips PA (July 1999). "Interaction between endothelin and angiotensin II". Clinical and Experimental Pharmacology & Physiology. 26 (7): 517–8. doi:10.1046/j.1440-1681.1999.03069.x. PMID 10405777. S2CID 27296727.